Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants.

Study answer

What this study found

Overall, there was no convincing evidence that any alternative lipid emulsion was superior to pure soybean oil-based lipid emulsions in preterm infants. Across pooled comparisons, there were no statistically significant differences in death before discharge, growth, bronchopulmonary dysplasia/chronic lung disease, sepsis, severe retinopathy of prematurity, or parenteral nutrition-associated liver disease. Examples include MOFS-LE versus soybean oil-based lipid emulsion for death before discharge RR 1.26, 95% CI 0.68 to 2.31; BPD/CLD RR 1.02, 95% CI 0.70 to 1.49; and any sepsis RR 0.94, 95%…

Study & population

Systematic review and meta-analysis of randomized trials in preterm infants receiving parenteral nutrition in NICUs.

Intervention

The intervention was parenteral lipid emulsions for preterm infants, comparing newer alternative formulations with pure soybean oil-based lipid emulsions.

Key limitation

The evidence base was generally low to very low quality, with small, often single-center trials and substantial heterogeneity across lipid formulations, doses, durations, and outcome definitions.

View full study detailsView sourceOpen PDF

Original abstract